title: A randomized prospective double-blind placebo-controlled study of gallopamil, calcium antagonist of the verapamil type, in stable cyclosporine-treated renal transplant recipients.
authors.affiliation: Funktionsbereich Nephrologie, Medizinische Klinik IV, Zentrum der Inneren Medizin, J.W. Goethe-Universität, Theodor-Stern-Kai 7, 60590 Frankfurt/Main, Germany.
authors.forename: Jan
authors.initials: J
authors.lastname: Gossmann
authors.forename: U
authors.initials: U
authors.lastname: Mondorf
authors.forename: A
authors.initials: A
authors.lastname: Dietz
authors.forename: W
authors.initials: W
authors.lastname: Kramer
authors.forename: H-G
authors.initials: HG
authors.lastname: Kachel
authors.forename: H
authors.initials: H
authors.lastname: Geiger
authors.forename: E-H
authors.initials: EH
authors.lastname: Scheuermann
mesh_terms: D000328:Adult; D001794:Blood Pressure / Q000187:drug effects*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000097:blood / Q000627:therapeutic use*; D004311:Double-Blind Method; D005711:Gallopamil / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000502:physiology*; D010919:Placebos; D011446:Prospective Studies; D014508:Urea / Q000097:blood; D014527:Uric Acid / Q000097:blood; D014700:Verapamil / Q000627:therapeutic use
chemical_list: D002121:Calcium Channel Blockers; D007166:Immunosuppressive Agents; D010919:Placebos; D014527:Uric Acid; D005711:Gallopamil; D016572:Cyclosporine; D014508:Urea; D003404:Creatinine; D014700:Verapamil